Centre for Sustainable Healthcare collaboration

RNS Number : 3776G
Surgical Innovations Group PLC
25 November 2020

Surgical Innovations Group plc
("Surgical Innovations", "SI" or the "Company")


Centre for Sustainable Healthcare collaboration

Aiming to reduce the environmental impact of plastic waste in surgery


Surgical Innovations Group plc (AIM: SUN), the designer, manufacturer and distributor of innovative medical technology for minimally invasive surgery, announces its collaboration with the Centre for Sustainable Healthcare ("CSH") to support wider efforts in the UK and globally to reduce the environmental impact of plastic waste in surgery.


This new collaboration with CSH will enable the validation of the Company's environmental messaging and demonstrate the quantifiable cost and environmental savings from a 'greener' operating room.  This data will then help develop information and training for NHS hospitals and staff as they seek to fulfil obligations on sustainability in the NHS, and follows the publication in October 2020 of the NHS 'Net Zero' objective, described more fully in the link below. Surgical Innovations' range of 'Resposable™' surgical instruments is designed to provide class leading quality and functionality, whilst reducing plastic waste by approximately 70% compared to that generated from commonly used competing products.  In addition, CSH's global network will help direct the Company's efforts to promote the Green credentials of its "Resposable™ product portfolio to existing and new international partners.


The Centre for Sustainable Healthcare is an independent registered charity. Established in 2008, it works to help the NHS fulfil its commitment to reduce its carbon footprint by 80% by 2050. It is now the one of the foremost institutions in the world working on sustainable healthcare in research and practice.


Adam Power, Group Development Director of SI, said: "The Centre for Sustainable Healthcare is a leading independent provider of information and training to NHS clinical staff and will be enormously helpful in providing Surgical Innovations with an ethical and rigorous pathway to providing hospitals with the information they need to fulfil the obligations set by NHS England in the recent plan: ' Delivering a 'Net Zero' National Health Service . ' (1)"


Rachel Stancliffe, Founder and Director of the Centre for Sustainable Healthcare, said: "We are delighted to be working with the team at Surgical Innovations. Good, collaborative and ethical industry partners are a vital part of transforming our health system for a sustainable future. Medical devices make up a significant proportion of the carbon footprint of hospitals and more sustainable alternatives are urgently needed if we are to meet our targets for reducing environmental impact. SI has developed a practical, accessible alternative to single-use surgical instruments and we look forward to working closely to increase uptake of this and other innovative alternatives."


(1)  https://www.england.nhs.uk/greenernhs/wp-content/uploads/sites/51/2020/10/delivering-a-net-zero-national-health-service.pdf


For further information please contact:  


Surgical Innovations Group plc

www sigroupplc com

Nigel Rogers, Chairman

Tel: 0113 230 7597

Charmaine Day, Company Secretary

N+1 Singer (Nominated Adviser & Broker)

Tel: 020 7496 3000

Aubrey Powell (Corporate Finance)

Rachel Hayes (Corporate Broking)

Walbrook PR (Financial PR & Investor Relations)

Tel: 020 7933 8780 or si@walbrookpr.com

Paul McManus / Lianne Cawthorne

Mob: 07980 541 893 / 07584 391 303


This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
UK 100